Steve Arkinstall has been named Chief Scientific Officer and Nigel Clark Vice President and Head of Business Development.
Kymab Strengthens Management Team with Two Senior Appointments
Steve Arkinstall has been named Chief Scientific Officer and Nigel Clark Vice President and Head of Business Development.
Tags
Related posts
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
